אולטיוה 5 מג
Country: Iżrael
Lingwa: Ebrajk
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
REMIFENTANIL AS HYDROCHLORIDE
Disponibbli minn:
PADAGIS ISRAEL AGENCIES LTD, ISRAEL
Kodiċi ATC:
N01AH06
Għamla farmaċewtika:
אבקה לשיקום להכנת תמיסה לזריקה
Kompożizzjoni:
REMIFENTANIL AS HYDROCHLORIDE 5 MG/VIAL
Rotta amministrattiva:
תוך-ורידי
Tip ta 'preskrizzjoni:
מרשם נדרש
Manifatturat minn:
GLAXO SMITHKLINE MANUFACTURING S.P.A., ITALY
Grupp terapewtiku:
REMIFENTANIL
Żona terapewtika:
REMIFENTANIL
Indikazzjonijiet terapewtiċi:
Ultiva is indicated for I.V. administration as an analgesic for use during induction and maintenance of general anaesthesia for inpatient and outpatient procedures under direct supervision of an anesthetist. Remifentanil is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients.
Data ta 'l-awtorizzazzjoni:
2022-12-31
